Related Experiment Videos
A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on
M Hussain1, M Herrmann, C von Eiff
1Institute of Medical Microbiology, University Hospital, Muenster, Germany.
Abstract:
Two distinct pathogenic mechanisms, adhesion to polymer surfaces and subsequent accumulation of sessile bacterial cells, are considered important pathogenic steps in foreign body infections caused by Staphylococcus epidermidis. By using mitomycin mutagenesis, we have recently generated a mutant, strain M7, from S. epidermidis RP62A which is unaffected in adhesion but deficient in accumulation on glass or polystyrene surfaces and lacks a 115-kDa extracellular protein (designated the 140-kDa antigen; F. Schumacher-Perdreau, C. Heilmann, G. Peters, F. Götz, and G. Pulverer, FEMS Microbiol. Lett. 117:71-78, 1994). To evaluate the role of this protein in accumulation, we harvested extracellular proteins from S. epidermidis RP62A grown on dialysis membranes placed over chemically defined medium, purified the protein by using ion-exchange chromatography, determined its N-terminal amino acid sequence, and raised antiserum in rabbits. The antibody recognized only a single band in a Western immunoblot of the crude extracellular extract. With the microtiter biofilm test, antiserum at a dilution of < or =1:1,000 blocked accumulation of RP62A up to 98% whereas preimmune serum did not. The 140-kDa antigen was found only in extracellular products from bacteria grown under sessile conditions. Of 58 coagulase-negative clinical isolates, 32 strains were 140-kDa antigen positive and produced significantly larger amounts of biofilm than the 26 strains that were 140-kDa antigen negative. The 140-kDa protein appears to be biochemically and functionally unrelated to any previously described factors associated with biofilm formation. Thus, the 140-kDa antigen, referred to as accumulation-associated protein, may be a factor essential in S. epidermidis accumulation and, due to its immunogenicity, may allow the development of novel immunotherapeutic strategies for prevention of foreign body infection.
Insights
A newly identified 140-kDa antigen in Staphylococcus epidermidis is crucial for bacterial accumulation in foreign body infections. This accumulation-associated protein may offer new targets for preventing infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Biochemistry
Background:
- Foreign body infections caused by Staphylococcus epidermidis involve bacterial adhesion and accumulation.
- A mutant strain M7, deficient in accumulation, lacks a 115-kDa extracellular protein, designated the 140-kDa antigen.
- The role of this protein in bacterial accumulation requires further investigation.
Purpose of the Study:
- To evaluate the role of the 140-kDa antigen in Staphylococcus epidermidis accumulation.
- To investigate the potential of the 140-kDa antigen as a target for immunotherapeutic strategies.
Main Methods:
- Purification of the 140-kDa antigen from extracellular products of S. epidermidis RP62A.
- Determination of the N-terminal amino acid sequence and generation of specific antiserum.
- Evaluation of antiserum efficacy in blocking bacterial accumulation using the microtiter biofilm test.
- Analysis of 140-kDa antigen presence in clinical isolates and correlation with biofilm production.
Main Results:
- Antiserum against the 140-kDa antigen effectively blocked bacterial accumulation by up to 98%.
- The 140-kDa antigen was exclusively found in extracellular products from sessile bacteria.
- A majority of clinical isolates (32/58) were positive for the 140-kDa antigen and produced more biofilm.
- The 140-kDa protein is biochemically and functionally distinct from known biofilm formation factors.
Conclusions:
- The 140-kDa antigen, termed accumulation-associated protein, is essential for Staphylococcus epidermidis accumulation.
- Its immunogenicity suggests potential for developing novel immunotherapies against foreign body infections.
- Targeting this protein could be a key strategy in preventing S. epidermidis-related foreign body infections.